Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schwartzkopff

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
MMW, Munchener Medizinische Wochenschrift|April 13, 1979
[Clofibrate banned - what now? (author's transl)]W Schwartzkopff
Arzneimittel-Forschung|January 1, 1983
Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphateW Krause, W Schwartzkopff
MMW, Munchener Medizinische Wochenschrift|May 9, 1975
[Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)]W Schwartzkopff, E Russ
Artery|January 1, 1980
Frequently used lipid-lowering drugs having no guaranteed effectW Scheffler, W Schwartzkopff
Medizinische Klinik|February 17, 1978
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)]W Schwartzkopff, M Zschiedrich
Deutsche Medizinische Wochenschrift (1946)|April 11, 1975
[Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)]W Schwartzkopff, E Russ
MMW, Munchener Medizinische Wochenschrift|November 24, 1978
[Dose-effect of beta-sitosterin in type IIa and IIb hypercholesterolemias (author's transl)]W Schwartzkopff, H J Jantke
Arzneimittel-Forschung|December 1, 1990
[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia]W Schwartzkopff, A Bimmermann, J Schleicher
Diabetes|July 1, 1976
Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Hyperinsulinism and its relationships to hypertriglyceridemia and overweightF Sorge, W Schwartzkopff, G A Neuhaus
Developments in Biological Standardization|January 1, 1980
Physiological aspects of the role of human albumin in the treatment of chronic and acute blood lossW Schwartzkopff, B Schwartzkopff, W Wurm, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
MMW, Munchener Medizinische Wochenschrift|April 13, 1979
[Clofibrate banned - what now? (author's transl)]W Schwartzkopff
Arzneimittel-Forschung|January 1, 1983
Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphateW Krause, W Schwartzkopff
MMW, Munchener Medizinische Wochenschrift|May 9, 1975
[Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)]W Schwartzkopff, E Russ
Artery|January 1, 1980
Frequently used lipid-lowering drugs having no guaranteed effectW Scheffler, W Schwartzkopff
Medizinische Klinik|February 17, 1978
[Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)]W Schwartzkopff, M Zschiedrich
Deutsche Medizinische Wochenschrift (1946)|April 11, 1975
[Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)]W Schwartzkopff, E Russ
MMW, Munchener Medizinische Wochenschrift|November 24, 1978
[Dose-effect of beta-sitosterin in type IIa and IIb hypercholesterolemias (author's transl)]W Schwartzkopff, H J Jantke
Arzneimittel-Forschung|December 1, 1990
[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia]W Schwartzkopff, A Bimmermann, J Schleicher
Diabetes|July 1, 1976
Insulin response to oral glucose in patients with a previous myocardial infarction and in patients with peripheral vascular disease. Hyperinsulinism and its relationships to hypertriglyceridemia and overweightF Sorge, W Schwartzkopff, G A Neuhaus
Developments in Biological Standardization|January 1, 1980
Physiological aspects of the role of human albumin in the treatment of chronic and acute blood lossW Schwartzkopff, B Schwartzkopff, W Wurm, et al.
Pageof 2